Cargando…

Expression of MRP and cMOAT in Childhood Neuroblastomas and Malignant Liver Tumors and Its Relevance to Clinical Behavior

Advanced neuroblastoma and malignant liver tumor are representative childhood cancers for which combined chemotherapy including cisplatin and doxorubicin is routinely performed. The prognosis of patients with tumors which develop multiple drug resistance (MDR) is unfavorable. To elucidate the role o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsunaga, Tadashi, Shirasawa, Hiroshi, Hishiki, Tomoro, Enomoto, Hideki, Kouchi, Katsunori, Ohtsuka, Yasuhiro, Iwai, Jun, Yoshida, Hideo, Tanabe, Masahiro, Kobayashi, Susumu, Asano, Takehide, Etoh, Takao, Nishi, Yoshisuke, Ohnuma, Naomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1998
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921738/ https://www.ncbi.nlm.nih.gov/pubmed/10081488 http://dx.doi.org/10.1111/j.1349-7006.1998.tb00524.x

Ejemplares similares

MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver
por: Belinsky, M G, et al.
Publicado: (1999)

MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor
por: Halon, Agnieszka, et al.
Publicado: (2012)

In vivo Cisplatin Resistance Depending upon Canalicular Multispecific Organic Anion Transporter (cMOAT)
por: Minamino, Tomoyoshi, et al.
Publicado: (1999)

Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.
por: Oguri, T., et al.
Publicado: (1998)

Sindbis viral structural protein cytotoxicity on human neuroblastoma cells
por: Saito, Eriko Y., et al.
Publicado: (2020)

Why moats matter: the Morningstar approach to stock investing
por: Brilliant, Heather, et al.
Publicado: (2014)

The spatial and temporal reconstruction of a medieval moat ecosystem
por: Antczak-Orlewska, Olga, et al.
Publicado: (2022)

Plasmonic Probe With Circular Nano-Moat for far-Field Free Nanofocusing
por: Zhang, Mingqian, et al.
Publicado: (2016)

Antibody‐dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells
por: Mise, Naoko, et al.
Publicado: (2016)

MOAT: efficient detection of highly mutated regions with the Mutations Overburdening Annotations Tool
por: Lochovsky, Lucas, et al.
Publicado: (2018)

Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation
por: Harada, Kazuaki, et al.
Publicado: (2019)

Quantitative study on the three-dimensional defense of Puzhuang Suo-Fort ancient wall and the moat
por: Shen, Shenge, et al.
Publicado: (2023)

Hepatic expression of multidrug resistance protein 2 in biliary atresia
por: Terui, Keita, et al.
Publicado: (2011)

Urinary amylase / urinary creatinine ratio (uAm/uCr) - a less-invasive parameter for management of hyperamylasemia
por: Terui, Keita, et al.
Publicado: (2013)

Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG) †
por: Ohira, Miki, et al.
Publicado: (2021)

MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells
por: Peaston, A E, et al.
Publicado: (2001)

The Seventh Annual Bio-Ontologies Meeting Moat House Hotel, Glasgow, 30 July 2004
por: Lord, Phillip, et al.
Publicado: (2004)

Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
por: Shinno, Yoshitaka, et al.
Publicado: (2022)

ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma
por: Huynh, Tony, et al.
Publicado: (2012)

Complete Genome Sequence of Magnetospirillum sp. Strain XM-1, Isolated from the Xi’an City Moat, China
por: Wang, Yinzhao, et al.
Publicado: (2016)

Exploring the Factors That Influence Stakeholder Participation in Decision-Making for the Moat System Restoration Project in Tianchang City, China
por: Yan, Shihua, et al.
Publicado: (2023)

Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4
por: Lee, Hee-Jeong, et al.
Publicado: (2022)

Malignant Rhabdoid Tumor of the Liver: A Case Report and Literature Review
por: Oita, Satoru, et al.
Publicado: (2015)

Wnt‐β‐catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer
por: Kobayashi, Minoru, et al.
Publicado: (2016)

The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma
por: Jin, Guang-Zhi, et al.
Publicado: (2015)

Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport
por: Zhao, Xiaofen, et al.
Publicado: (2019)

Myeloid-related protein (MRP) 8 and MRP 14 in rheumatoid arthritis and spondyloarthropathy
por: De Rycke, L, et al.
Publicado: (2003)

Serum MRP8/MRP14 as a biomarker for inflammation in autoimmune arthritis
por: De Rycke, L, et al.
Publicado: (2004)

Multi-state outcome analysis of treatments (MOAT): application of a new approach to evaluate outcomes in longitudinal studies of bipolar disorder
por: Bowden, C L, et al.
Publicado: (2016)

Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle
por: Engelhardt, Britta, et al.
Publicado: (2011)

The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils
por: Stroncek, David F, et al.
Publicado: (2005)

MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma
por: Lin, Shibo, et al.
Publicado: (2013)

Measurement of blood calprotectin (MRP-8/MRP-14) levels in patients with juvenile idiopathic arthritis
por: Bojko, Jaryna
Publicado: (2017)

MRP5 and MRP9 play a concerted role in male reproduction and mitochondrial function
por: Chambers, Ian G., et al.
Publicado: (2022)

Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR
por: Bin Kanner, Yuval, et al.
Publicado: (2023)

Antiretroviral treatment and expression of the mRNA levels for Pgp, MRP1, MRP4 and MRP5 in HIV antiretroviral naïve patients. Follow-up at 48 weeks
por: Falasca, Francesca, et al.
Publicado: (2010)

Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists' input to improve patient outcomes. Protocol for an observational study
por: Geeson, Cathy, et al.
Publicado: (2017)

Clinicopathological Impact of ABCC1/MRP1 and ABCC4/MRP4 in Epithelial Ovarian Carcinoma
por: Bagnoli, Marina, et al.
Publicado: (2013)

Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT
por: Roundhill, E, et al.
Publicado: (2013)

Significance of the expression of MRP1 and MRP2 in peripheral blood mononuclear cells of children with intractable epilepsy
por: LIU, XIAOMING, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t1p8l5ac11drahnvp1mfeskfkd